DANIELLI, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 1.592
EU - Europa 1.229
AS - Asia 638
SA - Sud America 90
AF - Africa 9
OC - Oceania 1
Totale 3.559
Nazione #
US - Stati Uniti d'America 1.568
RU - Federazione Russa 379
SG - Singapore 296
GB - Regno Unito 213
IE - Irlanda 213
CN - Cina 204
IT - Italia 111
BR - Brasile 80
DE - Germania 77
SE - Svezia 71
HK - Hong Kong 52
UA - Ucraina 46
FR - Francia 42
VN - Vietnam 25
FI - Finlandia 22
ES - Italia 21
KR - Corea 15
CA - Canada 12
MX - Messico 9
IN - India 8
BD - Bangladesh 6
PL - Polonia 6
ZA - Sudafrica 6
AZ - Azerbaigian 5
JP - Giappone 5
AT - Austria 4
PK - Pakistan 4
AR - Argentina 3
BE - Belgio 3
LT - Lituania 3
NL - Olanda 3
TR - Turchia 3
UZ - Uzbekistan 3
BG - Bulgaria 2
CH - Svizzera 2
CO - Colombia 2
EC - Ecuador 2
HR - Croazia 2
LK - Sri Lanka 2
OM - Oman 2
PA - Panama 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AU - Australia 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
PY - Paraguay 1
TL - Timor Orientale 1
UY - Uruguay 1
Totale 3.559
Città #
Fairfield 232
Dublin 213
Singapore 188
Southend 182
Dallas 141
Ashburn 135
Woodbridge 100
Moscow 95
Houston 94
Cambridge 91
Seattle 88
Beijing 79
Santa Clara 78
Wilmington 78
Hong Kong 52
Siena 50
Jacksonville 44
Chandler 40
Ann Arbor 39
Princeton 33
Shanghai 28
New York 22
Los Angeles 18
San Mateo 18
Helsinki 17
Málaga 17
Dearborn 14
San Diego 13
The Dalles 13
Dong Ket 11
Hefei 11
Munich 11
Nanjing 11
San Francisco 9
Buffalo 7
Düsseldorf 7
Montreal 7
Palermo 7
Seoul 7
Stockholm 7
Denver 6
London 6
Poplar 6
São Paulo 6
Yongsan-gu 6
Baku 5
Brooklyn 5
Frankfurt am Main 5
Lauterbourg 5
Venezia 5
Boston 4
Chicago 4
Ho Chi Minh City 4
Labico 4
Mexico City 4
Milan 4
Nanchang 4
Norwalk 4
Orem 4
Porto Alegre 4
Redondo Beach 4
Warsaw 4
Asciano 3
Boardman 3
Brussels 3
Guangzhou 3
Hanoi 3
Johannesburg 3
Kunming 3
Phoenix 3
Pistoia 3
Portsmouth 3
Redwood City 3
Tashkent 3
Tokyo 3
Toronto 3
Vienna 3
Amsterdam 2
Ankara 2
Araras 2
Bratislava 2
Cape Town 2
Changsha 2
Colombo 2
Falls Church 2
Florence 2
Guarulhos 2
Itajaí 2
Jackson 2
Jequié 2
Jinan 2
Manchester 2
Mumbai 2
Nuremberg 2
Paris 2
Rio de Janeiro 2
Riyadh 2
Saha-gu 2
Santo André 2
Sesto Fiorentino 2
Totale 2.501
Nome #
Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy) 325
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme 313
Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy 237
Ipilimumab in pretreated metastatic uveal melanoma patients: safety and clinical efficacy 235
Adjuvant vemurafenib in resected, BRAF V600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial 218
Circulating levels of PD-L1 in mesothelioma patients from the NIBIT-MESO-1 study: Correlation with survival 217
Guadecitabine plus ipilimumab in unresectable melanoma: the NIBIT-M4 clinical trial 199
Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma 189
“Cancer Bio-Immunotherapy in Siena”: Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17–19, 2013 178
Ipilimumab in the common daily practice: feasibility, safety, efficacy and long-term follow-up in heavily pretreated metastatic melanoma patients 173
Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies 165
Immunotherapy targeting immune check-point(s) in brain metastases 158
Eruptive porokeratosis under nivolumab adjuvant treatment for melanoma 157
Clinical studies with anti-CTLA-4 antibodies in non-melanoma indications 153
Clinical Efficacy of the Anti-Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Monoclonal Antibody Ipilimumab in Pretreated Metastatic Uveal Melanoma Patients 150
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian network for tumor biotherapy (NIBIT)-M1 phase II study 150
ICOS expression as immunologic marker in immune activating monoclonal antibodies 137
Efficacy of ipilimumab plus nivolumab or ipilimumab plus fotemustine vs fotemustine in patients with melanoma metastatic to the brain: Primary analysis of the phase III NIBIT-M2 trial 110
Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study 94
Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: An open-label, single-arm, phase 2 study 76
Totale 3.634
Categoria #
all - tutte 11.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.223


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021291 0 0 0 0 0 85 18 77 14 42 14 41
2021/2022259 19 38 23 5 11 12 14 14 13 32 28 50
2022/2023265 19 22 50 20 9 45 10 28 16 18 15 13
2023/2024318 11 7 52 12 7 72 121 4 0 0 14 18
2024/2025520 15 24 57 21 73 37 4 20 92 17 54 106
2025/2026976 93 125 106 206 430 16 0 0 0 0 0 0
Totale 3.634